Latest Global Markets News

Lode Resources reports exceptional high-grade antimony and silver drill results from its Montezuma Project in Tasmania, including the deepest mineralised intercept to date at 220m. These findings bolster the potential for a significant bulk tonnage resource amid soaring metal prices.

Southern Cross Gold Consolidated Ltd reports exceptional high-grade gold and antimony drill results from its Sunday Creek project in Victoria, revealing significant mineralization extensions both laterally and at depth.

ClearVue Technologies has unveiled its Gen3 Solar Vision Glass, achieving a 66% increase in energy output and a 50% reduction in production time and costs, validated by independent testing. This breakthrough positions the company for accelerated commercial adoption in solar-integrated building materials.

KMD Brands has launched a comprehensive transformation strategy aimed at unlocking brand potential and driving sustainable growth through cost reductions, product innovation, and digital acceleration.

Beetaloo Energy is gearing up for first gas production in 2026 from its Carpentaria Pilot Project, backed by a $65 million financing package and a binding 10-year gas sales agreement with the Northern Territory government.

Citigroup Global Markets Australia has declared a fully franked AUD 0.30 dividend for its ORG CitiFirst Self-Funding Instalment MINIs, reducing outstanding loan amounts and aligning dividend dates with ORG ordinary shares.

Advanced Braking Technology (ABT) reported robust FY25 financial results marked by revenue growth and improved profitability, while advancing its strategic roadmap focused on mining safety innovations and global market expansion.

Citigroup Global Markets Australia has announced a fully franked AUD 1.11 dividend for WES CitiFirst Self-Funding Instalments, aligning key dates with WES ordinary shares and reducing outstanding loan amounts on warrants.

Fat Prophets Global Contrarian Fund Ltd has reported a robust 56% increase in net profit for the year ended 30 June 2025, driven by strong investment returns and a leveraged global equity portfolio. The company also declared a fully franked special dividend, reflecting confidence in its ongoing performance.

HALO Technologies reports a significantly improved half-year net loss and secures verbal FCA approval for its UK platform, while preparing to launch Managed Funds in Australia.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.

Uscom Limited reported a 25% decline in revenue to $3.16 million and a 59% increase in net loss to $3.3 million for FY25, reflecting significant global headwinds. Despite setbacks, the company advanced new product approvals and secured funding to navigate ongoing challenges.